halothane has been researched along with Pulmonary Alveolar Proteinosis in 1 studies
Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blenkarn, GD | 1 |
| Lanning, CF | 1 |
| Kylstra, JA | 1 |
1 other study available for halothane and Pulmonary Alveolar Proteinosis
| Article | Year |
|---|---|
Anaesthetic management of volume controlled unilateral lung lavage.
Topics: Anesthesia, Endotracheal; Anesthesia, General; Anesthesia, Intravenous; Blood Pressure; Carbon Dioxi | 1975 |